Last reviewed · How we verify

Chlorhexidine gluconate soap

Johns Hopkins University · FDA-approved active Small molecule

Chlorhexidine gluconate is a broad-spectrum antimicrobial agent that disrupts bacterial cell membranes and denatures proteins, killing or inhibiting a wide range of microorganisms.

Chlorhexidine gluconate is a broad-spectrum antimicrobial agent that disrupts bacterial cell membranes and denatures proteins, killing or inhibiting a wide range of microorganisms. Used for Skin antisepsis and preoperative skin preparation, Antimicrobial skin cleansing, Surgical site infection prevention.

At a glance

Generic nameChlorhexidine gluconate soap
Also known asHibiclens
SponsorJohns Hopkins University
Drug classAntimicrobial agent / Antiseptic
ModalitySmall molecule
Therapeutic areaInfection Prevention / Dermatology
PhaseFDA-approved

Mechanism of action

Chlorhexidine is a cationic biguanide that binds to negatively charged bacterial cell membranes, causing leakage of cellular contents and cell death. It also precipitates bacterial proteins and nucleic acids. The gluconate salt formulation allows for use in topical soap preparations for skin antisepsis and antimicrobial cleansing.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: